Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Hydrogel Wound Dressing Market size & share revenue was valued at ...

Integra LifeSciences cuts 65 jobs at Princeton facility following device recall, joining wave of medtech layoffs affecting ...

Prabhudas Lilladher is bullish on Eris Lifesciences has recommended buy rating on the stock with a target price of Rs 1800 in its research report dated .

One month after Integra LifeSciences recalled its wound and burn devices amid safety concerns, the medtech company is cutting jobs at the New Jersey site where they are made. According to a new Worker ...

Skin health company and medical device manufacturer Newmedical Technology has acquired Derma Made. Derma Made’s offerings include accessible skin care solutions that also serve the clinical and ...

Add Yahoo as a preferred source to see more of our stories on Google. The U.S. Food and Drug Administration headquarters in Silver Spring, Md., on Nov. 10, 2020. Integra LifeSciences has recalled ...

Startups flush with cash are building AI-assisted laboratories to find materials far faster and more cheaply, but are still waiting for their ChatGPT moment. The microwave-size instrument at Lila ...

Look in the mirror. Really look. Do you see the skin on your arms starting to sag, creating those horizontal lines you swore you'd never get? Is your jawline becoming less defined, softening into the ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Abbott Laboratories $21 billion deal to acquire cancer test maker Exact ...

Abbott Laboratories ABT-0.97%decrease; red down pointing triangle agreed to acquire cancer diagnostics company Exact Sciences EXAS-0.07%decrease; red down pointing triangle in a deal valued at about ...

Abbott said on Thursday it would buy cancer test maker Exact Sciences in an up to $23 billion deal, bolstering the medical device maker's diagnostics business. This marks one of Abbott's largest deals ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...